Page last updated: 2024-10-30

losartan and Brain Diseases

losartan has been researched along with Brain Diseases in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research Excerpts

ExcerptRelevanceReference
"The results indicated that systemic inflammation had deleterious long-lasting consequences on brain, which were reversed by pretreatment with losartan."7.88Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection. ( Baghcheghi, Y; Beheshti, F; Hosseini, M; Khazaei, M; Sadeghnia, HR; Salmani, H; Shafei, MN; Soukhtanloo, M, 2018)
"The results indicated that systemic inflammation had deleterious long-lasting consequences on brain, which were reversed by pretreatment with losartan."3.88Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection. ( Baghcheghi, Y; Beheshti, F; Hosseini, M; Khazaei, M; Sadeghnia, HR; Salmani, H; Shafei, MN; Soukhtanloo, M, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salmani, H1
Hosseini, M1
Beheshti, F1
Baghcheghi, Y1
Sadeghnia, HR1
Soukhtanloo, M1
Shafei, MN1
Khazaei, M1

Other Studies

1 other study available for losartan and Brain Diseases

ArticleYear
Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection.
    Life sciences, 2018, Jun-15, Volume: 203

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Brain Diseases; Inflammation; Li

2018